1250479-78-7Relevant articles and documents
Synthesis and cytotoxicity of hybrids of 1,3,4- or 1,2,5-oxadiazoles tethered from ursane and lupane core with 1,2,3-triazole
Baev, Dmitry S.,Frolova, Tatiana S.,Popov, Sergey A.,Qi, Zhiwen,Semenova, Marya D.,Shestopalov, Michael A.,Shults, Elvira E.,Wang, Chengzhang,Turks, Māris
, (2020)
Ursane and lupane type (1-((5-aryl-1,3,4-oxadiazol-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl and (1-((4-methyl-2-oxido-1,2,5-oxadiazol-3-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl hybrids were prepared by 1,3-cycloaddition reactions of azole-derived azides w
One-potCuAAC synthesis of (1H-1,2,3-triazol-1-yl)methyl-1,3,4/1,2,4-oxadiazoles starting from available chloromethyl-1,3,4/1,2,4-oxadiazoles
Pokhodylo, Nazariy T.,Savka, Roman D.,Shyyka, Olga Ya.,Obushak, Mykola D.
, p. 2969 - 2976 (2020/05/25)
The one-pot CuAAC synthesis of (1H-1,2,3-triazol-1-yl)methyl-1,3,4-oxadiazole and (1H-1,2,3-triazol-1-yl)methyl-1,2,4-oxadiazole derivatives via three-component reaction of consequent nucleophilic substitution of chlorine, with azide, and its further “cli
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
-
Page/Page column 145; 146, (2013/09/26)
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula I: The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.
